Jeffrey Liebmann, MD
Enriched profileShirlee and Bernard Brown Professor of Ophthalmology; Vice-Chair, Department of Ophthalmology; Director, Glaucoma Division, Edward S. Harkness Eye Institute · Columbia University Vagelos College of Physicians and Surgeons
Jeffrey Liebmann is Shirlee and Bernard Brown Professor of Ophthalmology; Vice-Chair, Department of Ophthalmology; Director, Glaucoma Division, Edward S. Harkness Eye Institute at Columbia University Vagelos College of Physicians and Surgeons. OpenAlex indexes 852 publications with 23,949 citations (h-index 84); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Jeffrey Liebmann, MD, is Shirlee and Bernard Brown Professor of Ophthalmology at Columbia University Vagelos College of Physicians and Surgeons / Columbia University Irving Medical Center (Department of Ophthalmology, Edward S. Harkness Eye Institute). The public record shows 852 publications with 23,949 citations (h-index 84), centered on Glaucoma and retinal disorders, Retinal Diseases and Treatments, Corneal surgery and disorders. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 9 companies, 1 NIH-funded awards (1994–2008).
- Most recent indexed publication: 2024 · Eye (London, England)
- Top research focus: Glaucoma and retinal disorders
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 361.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin)
Sponsor: Columbia University
- Macular Damage in Early Glaucoma and Progression
Sponsor: Columbia University
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Kowa Pharmaceuticals America, Inc.Program year20251 payment
- ABBVIE INC.Program year20252 payments
- Alcon Vision LLCProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
79%Prostaglandin Analog35.8%Latanoprost70%Lumigan12%Travoprost7%Tafluprost5%Zioptan3%Travatan Z2%Xalatan1%Iyuzeh1%Part D<11 patientsCarbonic Anhydrase Inhibitor18.1%Dorzolamide-Timolol50%Dorzolamide Hcl21%Brinzolamide12%Simbrinza8%Azopt5%Acetazolamide Er3%Cosopt Pf2%Part D<11 patientsCardiovascular
14.7%Beta blocker14.7%Timolol Maleate89%Betimol4%Timoptic Ocudose3%Betoptic S2%Carteolol Hcl1%Part D<11 patientsNervous system
4.6%Cholinergic Receptor Agonist4.6%Pilocarpine Hcl100%Part D≥83 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 1994–2008 per NIH RePORTER. The latest:
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc.
Eye (London, England)
Clinical Trial2024 - The Glaucoma Suspect Problem: Ways Forward.
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Article2022
Most-cited works
by citation count (OpenAlex)- 01Glaucomatous damage of the macula869 citations2012
- 02EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS413 citations2004
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jeffrey-m-liebmann-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
vagelos.columbia.edu/profile/jeffrey-m-liebmann-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - ResearchGate
researchgate.net/scientific-contributions/Jeffrey-M-Liebmann-39752809
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
glaucomafoundation.org/our_staff/jeffrey-m-liebmann-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucomafoundation.org ↗ - Other
recruit.cumc.columbia.edu/investigatortrials/17239
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →recruit.cumc.columbia.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗
- Glaucoma fellowship
New York Eye and Ear Infirmary
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief (now Emeritus Editor-in-Chief per most recent listing)
Journal of Glaucoma
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucomafoundation.org ↗ - Member
Board of Governors, World Glaucoma Association; Past-President, World Glaucoma Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucomafoundation.org ↗ - Past-President
American Glaucoma Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.columbia.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.